State Street Corp Neurocrine Biosciences Inc Transaction History
State Street Corp
- $2.25 Trillion
- Q2 2024
A detailed history of State Street Corp transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, State Street Corp holds 4,608,357 shares of NBIX stock, worth $585 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
4,608,357
Previous 3,989,961
15.5%
Holding current value
$585 Million
Previous $550 Million
15.29%
% of portfolio
0.03%
Previous 0.02%
Shares
18 transactions
Others Institutions Holding NBIX
# of Institutions
625Shares Held
94.7MCall Options Held
642KPut Options Held
288K-
Black Rock Inc. New York, NY14.2MShares$1.8 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.28 Billion0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.47MShares$313 Million0.6% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.9MShares$241 Million4.37% of portfolio
-
Geode Capital Management, LLC Boston, MA1.86MShares$236 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $12.1B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...